Materials for blood brain barrier modeling in vitro

https://doi.org/10.1016/j.mser.2019.100522Get rights and content

Abstract

Brain homeostasis relies on the selective permeability property of the blood brain barrier (BBB). The BBB is formed by a continuous endothelium that regulates exchange between the blood stream and the brain. This physiological barrier also creates a challenge for the treatment of neurological diseases as it prevents most blood circulating drugs from entering into the brain. In vitro cell models aim to reproduce BBB functionality and predict the passage of active compounds through the barrier. In such systems, brain microvascular endothelial cells (BMECs) are cultured in contact with various biomaterial substrates. However, BMEC interactions with these biomaterials and their impact on BBB functions are poorly described in the literature. Here we review the most common materials used to culture BMECs and discuss their potential impact on BBB integrity in vitro. We investigate the biophysical properties of these biomaterials including stiffness, porosity and material degradability. We highlight a range of synthetic and natural materials and present three categories of cell culture dimensions: cell monolayers covering non-degradable materials (2D), cell monolayers covering degradable materials (2.5D) and vascularized systems developing into degradable materials (3D).

Introduction

Endothelial cells that line the inner surface of the vasculature are specialized according to the architecture and the need of the tissue it supplies [1]. In particular, brain microvascular endothelial cells (BMECs) that constitute brain capillaries, form a continuous endothelium that separates the cerebral tissue from the bloodstream. This endothelium, termed the blood brain barrier (BBB), maintains the stability of the brain tissue composition by regulating ion and macromolecule diffusion through the capillary wall [2]. The BBB ensures homeostasis in the central nervous system (CNS) by protecting neurons from the entrance of blood-circulating pathogenic agents into the brain. Therefore, CNS diseases such as amyotrophic lateral sclerosis, epilepsy, Alzheimer’s and Parkinson’s diseases are associated with BBB dysfunction [[3], [4], [5]]. Conversely, the BBB also rejects most of the large drugs (>400 Da) targeting the brain [6]. This renders drug accumulation at relevant therapeutic concentrations challenging, for treatment of a variety of neurological diseases. The development of BBB tissue models is of great importance to understand how the microenvironment influences the BBB selectivity property and establish new therapeutic strategies for drug diffusion into the brain [[7], [8], [9]].

In order to build relevant BBB tissue models, it is necessary to understand the in vivo structure of brain capillaries. A complex and dynamic microenvironment surrounds brain capillaries and influences BBB integrity. BMECs closely interact with two other cell types, pericytes and astrocytes, which wrap 30 % and 98 % of the surface of the endothelium, respectively[10]. They provide mechanical support for the vascular endothelium and secrete biochemical factors required to maintain BBB integrity [11,12]. Pericytes and astrocytes both participate in the maturation and maintenance of BBB properties [13]. In some brain diseases, both astrocytes and pericytes affect BBB selective permeability [14,15]. For example, during inflammation astrocytes secrete pro-inflammatory mediators that increase BBB permeability and support leukocyte infiltration [14]. During cerebral ischemia, pericytes represent a source of matrix metalloproteinases (MMPs) that locally degrade the BBB and contribute to plasma leakage [15]. Both pericytes and astrocytes are separated from the BMECs by a vascular basement membrane (BM). The BM provides mechanical support to the BMECs and retains most of the biochemical cues secreted by the surrounding cells. The diffusion gradient of these biochemical cues oriented towards the BBB strongly influences BBB integrity [16,17]. Finally, as part of the vascular system, the BMECs perceive active mechanical stimuliin the form of shear stress exerted by the blood flow and the circumferential stretch induced by blood pressure [18]. Recent studies document the impact of circulatory pressure and blood flow on blood brain barrier function [[18], [19], [20]]. Importantly, brain endothelial cells react to shear stress and circumferential stretch by remodeling their cytoskeletal filaments and producing stress fibers [[18], [19], [20]]. These fibers are aligned along the direction of flow and perpendicular to the direction of stretch. The development of BBB models to accurately predict the passage of drugs through the barrier relies on the integration of these biochemical and mechanical factors as parameters that participate in BBB maturation and function.

Two types of models are commonly used for drug testing: animal models and in vitro cell models. Animal models, compared to in vitro models, preserve the native matrix architecture and can further predict cellular response in a physiological context. However, when it comes to the BBB, there is a mismatch between animals and humans in terms of cellular and matrix composition. This usually renders animal models poorly predictive of the human BBB response. As a result, almost 80 % of animal-drug candidates fail in clinical trials due to high-level toxicity and/or low therapeutic efficiency. Conversely, in vitro cell models culture cells from a human origin in a well-defined environment to mimic tissue and organ functions. Various human brain endothelial cells have been successfully used to model aspects of the BBB, including immortalized cell lines, primary cells, and induced pluripotent stem cells (iPSC) [2,22,23]. BBB in vitro models rely on the culture of BMECs at the interface between two compartments, luminal and abluminal. Several cell culture configurations exist, which have been classified into three categories of models in this review: 2-dimensional (2D), 2.5D and 3D models. 2D models refer to the culture of BMEC monolayers on top of flat and stiff synthetic substrates [24]. Among them, the Transwell® model relies on the culture of BMECs on top of a suspended porous membrane. Transwells are commercially available and widely used to model the BBB for drug screening [25]. They offer easy access to both sides of the barrier and are relatively cheap and easy-to-use. However, they are poorly representative of BMEC native environment in term of substrate mechanical stiffness and cell curvature [26]. To overcome this limitation, soft cell-degradable materials, such as hydrogels, give rise to two main cell culture configurations [6]. The culture of BMEC monolayer inside a predesigned tubular structure made of hydrogels, named as 2.5D models in this review, and the embedding of cells into hydrogels to induce capillary angiogenesis, which we term 3D models in this review.

BMECs cultured within in vitro models are exposed to a variety of biochemical (e.g., cell culture media composition and substrate protein coating) and physical (e.g., substrate architecture and media flow) cues that may affect cell phenotype and impact the barrier formation. The impact of biochemical signaling cues on in vitro BBB formation and integrity is well-documented [27,28]. In the last decade, there have been multiple reports concerning the impact of shear stress on BBB integrity due to the introduction of mechanical stimuli from media flow applied to BMECs [[29], [30], [31]]. However, the impact of the matrix-induced mechanical signaling on in vitro BBB property has been poorly described (Fig. 1).

Here, we review materials that have been used as substrates to culture brain endothelial cells in 2D, 2.5D and 3D BBB models. We also explore how material properties, such as elasticity, structure, and degradability (by the cells during matrix remodeling), affect endothelial barrier function by developing an analytical framework to guide the use of BBB models. Ultimately, this review offers insight into the emerging organ-on-a-chip technology proposed as a promising option to fill the gap in drug screening. These new in vitro models include a variety of environmental factors, such as topographical guidance, mechanical stimulation, biochemical gradients and spatially defined co-culture [32]. BBB-on-a-chip models use biomimetic materials to culture BMECs indifferent configurations (e.g., 2D, 2.5D, and 3D) to improve endothelial barrier development and maintenance.

Section snippets

The blood brain barrier basement membrane

The basement membrane (BM) acts as a physical support to the BMECs. It also constitutes a source of biochemical and biophysical cues that both modulate BBB functions and integrity. The present section describes the composition and the architecture of the BBB BM. The interaction between the endothelial cells and the BM is presented here at the molecular, cellular and tissue scale.

Materials used to culture brain vascular endothelial cells

Materials that constitute the substrate for BBB cell model tend to reproduce all or part of the BM properties. As a result of their diversity in term of physico-chemical properties, these materials may impact the formation of the BBB in vitro differently.

Organ-on-a-chip systems: toward dynamic 2D, 2.5D, and 3D models

The emergence of microfabrication techniques combined with the recent progress in tissue engineering has given rise to a new class of in vitro models based on microfluidic devices. These new systems, named organ-on-a-chip, aim to reproduce organ functional units. This is achieved by culturing cells in a physiologically relevant microenvironment, in terms of geometrical, mechanical, and biochemical factors [141]. Microfluidic devices are particularly relevant to mimic vascular organs in vitro.

Challenges and Future directions: the use of conducting polymers for in vitro models of electrically active NVU tissue

As illustrated in this review, biochemical and mechanical parameters strongly impact BBB integrity. The development of new, beyond-2D in vitro models, integrating relevant biomaterials has allowed significant progress to be made in generating more physiologically relevant models for studying the BBB. However, the inclusion of electrical cues may also be advantageous for tissue development [155]. A consensus has arisen that the BBB should not be studied in isolation, and really should be studied

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

R.M.O. would like to acknowledge the Ecole des Mines Saint-Etienne/Institut Mines Télécom for Bourse Ecole (M.P.F.) and the H2020 ERC CoG grant “IMBIBE” GA No. 723951ERC. M.P.F. would like to acknowledge the France-Stanford Center for Interdisciplinary Studies and the Heilshorn Biomaterials Group. S.C.H. would like to thank support from the National Science Foundation (DMR 1808415) and National Institutes of Health (R01 EB02717). M.P.F. would like to thank Nicola Cavaleri for extensive review

Dr. Magali Ferro is currently a research associate at the University of Cambridge working on the NEPLEX Project (kidney on chip)under the guidance of Dr. Shery Huang. Following a degree in biotechnology at ENSAT in Toulouse and AgroParisTech, she did a Masters at the Unversity of Pierre and Marie Curie in Paris, specialising in neuroscience. She carried out her PhD in the dept. of bioelectronics at Ecole des Mines de St. Etienne, on the microelectronics campus in Provence under the supervision

References (176)

  • N.J. Abbott et al.

    Neurobiol. Dis.

    (2010)
  • S. Aday et al.

    Trends Biotechnol.

    (2016)
  • K. Schöller et al.

    Brain Res.

    (2007)
  • N.J. Abbott et al.

    Neurobiol. Dis.

    (2010)
  • K. Hatherell et al.

    J. Neurosci. Methods

    (2011)
  • A. Appelt-Menzel et al.

    Stem Cell Rep.

    (2017)
  • Y. Takeshita et al.

    J. Neurosci. Methods

    (2014)
  • F.E. Arthur et al.

    Dev. Brain Res.

    (1987)
  • M.G. McCoy et al.

    Acta Biomater.

    (2016)
  • I. Megard et al.

    Brain Res.

    (2002)
  • P.P. Partyka et al.

    Biomaterials

    (2017)
  • X. Shao et al.

    Analytica Chimica Acta

    (2016)
  • A. Pozzi et al.

    Matrix Biol.

    (2017)
  • R.C. Andresen Eguiluz et al.

    Biomaterials

    (2017)
  • K. Burridge et al.

    Exp. Cell Res.

    (2016)
  • A.A. Birukova et al.

    Microvasc. Res.

    (2013)
  • S. Noria et al.

    Am. J. Pathol.

    (2004)
  • K.M. Gray et al.

    Semin. Cell Dev. Biol.

    (2017)
  • E. Vandenhaute et al.

    Lab. Investig.

    (2016)
  • K. Hatherell et al.

    J. Neurosci. Methods

    (2011)
  • M. Potente et al.

    Nat. Rev. Mol. Cell Biol.

    (2017)
  • Z. Cai et al.

    J. Alzheimer Dis.

    (2018)
  • J. Kealy et al.

    Neurosci. Lett.

    (2018)
  • R.G. Rempe et al.

    J. Neurosci.

    (2018)
  • M.A. Kaisar et al.

    Expert Opin. Drug Discov.

    (2017)
  • L.-P. Wu et al.

    Nat. Commun.

    (2019)
  • A.D. Wong et al.

    Front. Neuroeng.

    (2013)
  • S. Nakagawa et al.

    Cell. Mol. Neurobiol.

    (2007)
  • Y. Yao et al.

    Nat. Commun.

    (2014)
  • A. Armulik et al.

    Nature

    (2010)
  • A.T. Argaw et al.

    J. Clin. Invest.

    (2012)
  • R.G. Underly et al.

    J. Neurosci.

    (2017)
  • M.S. Thomsen et al.

    J. Cereb. Blood Flow Metabol.

    (2017)
  • L. Cucullo et al.

    BMC Neurosci.

    (2011)
  • J.G. DeStefano et al.

    Fluids Barriers CNS

    (2017)
  • F. Garcia-Polite et al.

    J. Cereb. Blood Flow Metabol.

    (2017)
  • K. Lauschke et al.

    Stem Cells Devel.

    (2017)
  • E.S. Lippmann et al.

    Fluids Barriers CNS

    (2013)
  • J. Saji Joseph et al.
  • R. Cecchelli et al.

    Nat. Rev. Drug Discov.

    (2007)
  • M. Ye et al.

    Sci. Rep.

    (2014)
  • B. Obermeier et al.

    Nat. Med.

    (2013)
  • K. Zobel et al.

    Cell Tissue Res.

    (2016)
  • D.T. Phan et al.

    Exper. Biol. Med.

    (2017)
  • M.W. van der Helm et al.

    Tissue Barriers

    (2016)
  • B. Zhang et al.

    Lab Chip

    (2017)
  • Z. Maherally et al.

    FASEB J.

    (2017)
  • M.E. Katt et al.

    Fluids Barriers CNS

    (2018)
  • M.S. Thomsen et al.

    J. Neurochem.

    (2016)
  • Cited by (47)

    View all citing articles on Scopus

    Dr. Magali Ferro is currently a research associate at the University of Cambridge working on the NEPLEX Project (kidney on chip)under the guidance of Dr. Shery Huang. Following a degree in biotechnology at ENSAT in Toulouse and AgroParisTech, she did a Masters at the Unversity of Pierre and Marie Curie in Paris, specialising in neuroscience. She carried out her PhD in the dept. of bioelectronics at Ecole des Mines de St. Etienne, on the microelectronics campus in Provence under the supervision of Róisín M. Owens, working on in vitro models of human tissues, in particular the neurovascular unit.

    Professor Sarah Heilshorn completed her undergraduate studies in chemical engineering at Georgia Tech. She then earned her MS and PhD in chemical engineering at the California Institute of Technology (Caltech) under the supervision of David A. Tirrell. While a graduate student, she was also a visiting scholar in the Department of Polymer Science at the Kyoto Institute of Technology through a National Science Foundation East Asia Fellowship. She was awarded the Caltech Everhart Lectureship for her PhD thesis work in 2004. Following this, Prof. Heilshorn was a postdoctoral scholar with Mu-ming Poo at the University of California, Berkeley in the Department of Molecular and Cell Biology. In 2006 she joined Stanford University as an Assistant Professor in the Department of Materials Science & Engineering. She also holds courtesy faculty appointments in the Departments of Bioengineering and Chemical Engineering. Her research laboratory studies the dynamics of biological and bio-inspired systems at multiple length scales, including the molecular through to the multi-cellular level. Current topics of investigation include the design of injectable materials for stem cell and drug delivery, protein-engineered materials for regenerative medicine scaffolds, and peptide-based self-assembly materials for templated nanoparticle synthesis. In 2009, she was selected for the National Science Foundation CAREER Award and the National Institutes of Health New Innovator Award for young faculty. She has received many additional awards including the 3M Non-Tenured Faculty Award in 2014 and the University of Sydney International Research Collaboration Award in 2015. She has been elected fellow of the Royal Society of Chemistry and the American Institute for Medical and Biological Engineering.

    Dr. Róisín M. Owens is a University Lecturer at the Dept. of Chemical Engineering and Biotechnology in the University of Cambridge and a Fellow of Newnham College. She received her BA in Natural Sciences (Mod. Biochemistry) at Trinity College Dublin, and her PhD in Biochemistry and Molecular Biology at Southampton University. She carried out two postdoc fellowships at Cornell University, on host-pathogen interactions of Mycobacterium tuberculosis in the dept. of Microbiology and Immunology with Prof. David Russell, and on rhinovirus therapeutics in the dept. of Biomedical Engineering with Prof. Moonsoo Jin. From 2009–2017 she was a group leader in the dept. of bioelectronics at Ecole des Mines de St. Etienne, on the microelectronics campus in Provence. Her current research centers on application of organic electronic materials for monitoring biological systems in vitro, with a specific interest in studying the gut-brain-microbiome axis. She has received several awards including the European Research Council starting (2011), proof of concept grant (2014) and consolidator (2016) grants, a Marie Curie fellowship, and an EMBO fellowship. In 2014, she became principle editor for biomaterials for MRS communications (Cambridge University Press), and she serves on the advisory board of Advanced BioSystems and Journal of Applied Polymer Science (Wiley). She is author of 70+ publications and 2 patents. She is a 2019 laureate of the Suffrage Science award.

    View full text